Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phenobarbital--thioridazine interaction in man.

G L Ellenor, M N Musa, F C Beuthin

    Research Communications in Chemical Pathology and Pharmacology
    |July 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Potential Health Benefits of Deep Sea Water: A Review.

    Evidence-based complementary and alternative medicine : eCAM·2017
    Same author

    Adverse events of fluoxetine: postmarketing compared with premarketing clinical trials.

    The Journal of clinical psychiatry·2000
    Same author

    Nefazodone in patients with treatment-refractory posttraumatic stress disorder.

    The Journal of clinical psychiatry·2000
    Same author

    Paroxetine for primary insomnia: possible placebo effect?

    The Journal of clinical psychiatry·1999
    Same author

    Haemophilus influenzae meningitis in Malaysia.

    The Pediatric infectious disease journal·1998
    Same author

    Pharmaceutical care role model in psychiatry--pharmacist prescribing.

    Hospital pharmacy·1995

    Phenobarbital withdrawal increased thioridazine levels in patients. This drug interaction highlights the need for careful monitoring during dosage adjustments for these psychiatric medications.

    Area of Science:

    • Pharmacology
    • Neuroscience
    • Clinical Pharmacy

    Background:

    • Thioridazine is an antipsychotic medication.
    • Phenobarbital is a sedative-hypnotic drug.
    • Drug interactions can alter medication efficacy and safety.

    Purpose of the Study:

    • To investigate the effect of phenobarbital withdrawal on plasma thioridazine levels.
    • To explore potential mechanisms behind this drug interaction.

    Main Methods:

    • Plasma thioridazine levels were measured in seven patients.
    • Patients underwent gradual phenobarbital withdrawal.
    • Thioridazine and its metabolites were quantified.

    Main Results:

    • Plasma thioridazine and metabolite levels increased as phenobarbital dosage decreased.

    Related Experiment Videos

  • A clear correlation was observed between decreasing phenobarbital dose and rising thioridazine levels.

    • Conclusions:

    • Phenobarbital withdrawal significantly impacts thioridazine pharmacokinetics.
    • This interaction may be due to altered drug metabolism or transport.
    • Clinical monitoring is crucial when adjusting phenobarbital doses in patients on thioridazine.